Comment
doi: 10.1111/add.16481.
Epub 2024 Mar 12.
Commentary on Amin-Esmaeili et al.: Non-abstinence outcomes in stimulant clinical trials-Why deny improvement?
Affiliations
- PMID: 38476049
- DOI: 10.1111/add.16481
Item in Clipboard
Comment
Commentary on Amin-Esmaeili et al.: Non-abstinence outcomes in stimulant clinical trials-Why deny improvement?
Addiction.
2024 May.
No abstract available
Keywords: abstinence; clinical trials; cocaine; methamphetamine; outcomes; stimulants.
Comment on
-
Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.Addiction. 2024 May;119(5):833-843. doi: 10.1111/add.16409. Epub 2024 Jan 10. Addiction. 2024. PMID: 38197836 Free PMC article. Clinical Trial.
Similar articles
-
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255. doi: 10.1007/s00213-020-05563-3. Epub 2020 Jun 29. Psychopharmacology (Berl). 2020. PMID: 32601988
-
Commentary on Zolopa et al.: Trauma as an impediment to successful aging and a precipitant of opioid and stimulant use among older adults.Addiction. 2022 Aug;117(8):2189-2190. doi: 10.1111/add.15877. Epub 2022 Mar 29. Addiction. 2022. PMID: 35352411 Free PMC article. No abstract available.
-
Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.Addiction. 2015 May;110(5):875-6. doi: 10.1111/add.12885. Epub 2015 Mar 23. Addiction. 2015. PMID: 25808040 Free PMC article. No abstract available.
-
Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.Arch Gen Psychiatry. 2005 Oct;62(10):1148-56. doi: 10.1001/archpsyc.62.10.1148. Arch Gen Psychiatry. 2005. PMID: 16203960 Clinical Trial.
-
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.Drug Alcohol Depend. 2020 Nov 1;216:108193. doi: 10.1016/j.drugalcdep.2020.108193. Epub 2020 Aug 1. Drug Alcohol Depend. 2020. PMID: 32861136 Free PMC article.
References
REFERENCES
-
- Amin‐Esmaeili M, Farokhnia M, Susukida R, Leggio L, Johnson RM, Crum RM, et al. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: findings from 13 multisite randomized clinical trials. Addiction. 2024;119:833–843. https://doi.org/10.1111/add.16409
-
- Carroll KM, Kiluk BD, Nich C, DeVito EE, Decker S, LaPaglia D, et al. Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend. 2014;137:3–19. https://doi.org/10.1016/j.drugalcdep.2014.01.012
-
- Cumming C, Troeung L, Young JT, Kelty E, Preen DB. Barriers to accessing methamphetamine treatment: a systematic review and meta‐analysis. Drug Alcohol Depend. 2016;168:263–273. https://doi.org/10.1016/j.drugalcdep.2016.10.001
-
- Wallach JD, Krystal JH, Ross JS, O'Malley SS. Characteristics of ongoing clinical trials for alcohol use disorder registered on ClinicalTrials.gov. JAMA Psychiatry. 2020;77(10):1081–1084. https://doi.org/10.1001/jamapsychiatry.2020.1167
-
- Shmulewitz D, Aharonovich E, Witkiewitz K, Anton RF, Kranzler HR, Scodes J, et al. The World Health Organization risk drinking levels measure of alcohol consumption: prevalence and health correlates in nationally representative surveys of U.S. adults, 2001‐2002 and 2012‐2013. Am J Psychiatry. 2021;178(6):548–559. https://doi.org/10.1176/appi.ajp.2020.20050610
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
